Naohiko Seki

20.8k total citations · 1 hit paper
357 papers, 16.4k citations indexed

About

Naohiko Seki is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Naohiko Seki has authored 357 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 286 papers in Molecular Biology, 181 papers in Cancer Research and 37 papers in Oncology. Recurrent topics in Naohiko Seki's work include MicroRNA in disease regulation (154 papers), Cancer-related molecular mechanisms research (113 papers) and RNA modifications and cancer (86 papers). Naohiko Seki is often cited by papers focused on MicroRNA in disease regulation (154 papers), Cancer-related molecular mechanisms research (113 papers) and RNA modifications and cancer (86 papers). Naohiko Seki collaborates with scholars based in Japan, United States and United Kingdom. Naohiko Seki's co-authors include Hideki Enokida, Masayuki Nakagawa, Takeshi Chiyomaru, Hirofumi Yoshino, Nijiro Nohata, Naoko Kikkawa, Toyoyuki Hanazawa, Yusuke Goto, Takashi Kinoshita and Tomohiko Ichikawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Naohiko Seki

352 papers receiving 16.2k citations

Hit Papers

Hereditary progressive dy... 1994 2026 2004 2015 1994 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naohiko Seki Japan 70 12.1k 8.2k 2.1k 1.4k 1.1k 357 16.4k
Leonardo Salmena Canada 31 13.9k 1.2× 9.0k 1.1× 1.9k 0.9× 1.0k 0.7× 1.5k 1.4× 66 16.6k
Akiko Hata United States 51 9.9k 0.8× 3.8k 0.5× 1.8k 0.9× 1.1k 0.8× 1.2k 1.1× 109 13.2k
Sven Diederichs Germany 47 12.4k 1.0× 11.1k 1.4× 1.9k 0.9× 1.2k 0.9× 784 0.7× 112 15.6k
Roy Bicknell United Kingdom 72 10.2k 0.8× 4.2k 0.5× 3.7k 1.7× 1.4k 1.0× 1.7k 1.6× 232 16.1k
Gregory J. Goodall Australia 61 13.3k 1.1× 9.5k 1.2× 2.8k 1.3× 856 0.6× 1.6k 1.5× 149 17.2k
Michael I. Lerman United States 61 10.2k 0.8× 4.3k 0.5× 2.6k 1.2× 2.9k 2.1× 971 0.9× 165 14.5k
Akira Nakagawara Japan 69 11.4k 0.9× 4.4k 0.5× 5.3k 2.5× 1.3k 0.9× 1.4k 1.3× 347 18.0k
Eva Hernando United States 52 10.6k 0.9× 5.6k 0.7× 3.3k 1.5× 967 0.7× 2.0k 1.8× 115 14.5k
Brian Keith United States 44 7.5k 0.6× 6.8k 0.8× 3.4k 1.6× 1.3k 1.0× 1.6k 1.5× 65 13.7k
Leif W. Ellisen United States 54 9.4k 0.8× 3.9k 0.5× 4.9k 2.3× 1.6k 1.1× 1.2k 1.1× 152 15.9k

Countries citing papers authored by Naohiko Seki

Since Specialization
Citations

This map shows the geographic impact of Naohiko Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohiko Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohiko Seki more than expected).

Fields of papers citing papers by Naohiko Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naohiko Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohiko Seki. The network helps show where Naohiko Seki may publish in the future.

Co-authorship network of co-authors of Naohiko Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Naohiko Seki. A scholar is included among the top collaborators of Naohiko Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naohiko Seki. Naohiko Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kasamatsu, Atsushi, Kohei Kawasaki, Tomoaki Saito, et al.. (2024). Synthetic Circular RNA for microRNA-1269a Suppresses Tumor Progression in Oral Squamous Cell Carcinoma. Cancers. 16(6). 1242–1242. 4 indexed citations
2.
Yonezawa, Hajime, et al.. (2024). Therapeutic effects of an ALK inhibitor, brigatinib, on lung large cell neuroendocrine carcinoma with EML4-ALK fusion. Respiratory Investigation. 62(6). 1157–1160. 2 indexed citations
3.
4.
Kurozumi, Sasagu, Naohiko Seki, Chikako Honda, et al.. (2023). Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer. International Journal of Molecular Sciences. 25(1). 35–35. 3 indexed citations
5.
Misono, Shunsuke, Naoko Kikkawa, Takayuki Suetsugu, et al.. (2023). Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets. FEBS Open Bio. 13(9). 1737–1755. 5 indexed citations
7.
Potluri, Sandeep, Salam A. Assi, Paulynn Suyin Chin, et al.. (2021). Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1. Cell Reports. 35(3). 109010–109010. 14 indexed citations
8.
Koshizuka, Keiichi, Toyoyuki Hanazawa, Ichiro Fukumoto, et al.. (2016). The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma. Journal of Human Genetics. 62(1). 3–13. 40 indexed citations
9.
Minami, Kentaro, Sho Tabata, Masatatsu Yamamoto, et al.. (2014). Expression of ABCB6 is related to resistance to 5-FU, SN-38 and vincristine.. PubMed. 34(9). 4767–73. 24 indexed citations
10.
Tachiwada, Tokushi, Zhe‐Sheng Chen, Xiaofang Che, et al.. (2007). Isolation and characterization of arsenite-resistant human epidermoid carcinoma KB cells. Oncology Reports. 18(3). 721–7. 7 indexed citations
11.
Onda, Takeshi, Katsuhiro Uzawa, Dai Nakashima, et al.. (2007). Lin-7C/VELI3/MALS-3: An Essential Component in Metastasis of Human Squamous Cell Carcinoma. Cancer Research. 67(20). 9643–9648. 23 indexed citations
12.
Ohtsuka, Masayuki, Hiroshi Itô, Fumio Kimura, et al.. (2006). Relationship Between Pancreatic Secretory Trypsin Inhibitor and Early Recurrence of Intrahepatic Cholangiocarcinoma Following Surgical Resection. The American Journal of Gastroenterology. 101(7). 1601–1610. 28 indexed citations
13.
Kato, Masaki, Yoshinori Nimura, Naohiko Seki, et al.. (2006). Up-regulation of genes for oxidative phosphorylation and protein turnover in diabetic mouse retina. Experimental Eye Research. 83(4). 849–857. 11 indexed citations
14.
Kouzu, Yukinao, Katsuhiro Uzawa, Masaki Kato, et al.. (2006). WISP-2 expression in human salivary gland tumors. International Journal of Molecular Medicine. 17(4). 567–73. 16 indexed citations
15.
Uzawa, Katsuhiro, Kazuki Saito, Dai Nakashima, et al.. (2006). Gene expression pattern in oral cancer cervical lymph node metastasis. Oncology Reports. 16(5). 1009–14. 18 indexed citations
16.
Ozaki, Toshinori, Takahiro Nagase, Shingo Ichimiya, et al.. (2000). NFBD1/KIAA0170 Is a Novel Nuclear Transcriptional Transactivator with BRCT Domain. DNA and Cell Biology. 19(8). 475–485. 39 indexed citations
17.
Ueki, Nobuhide, Naohiko Seki, Kazuhiro Yano, et al.. (1999). Isolation, tissue expression, and chromosomal assignment of a human LIM protein gene, showing homology to rat Enigma homologue (ENH). Journal of Human Genetics. 44(4). 256–260. 32 indexed citations
18.
Asaumi, Sunao, Hidehito Kuroyanagi, Naohiko Seki, & Takuji Shirasawa. (1999). Orthologues of the Caenorhabditis elegans Longevity Gene clk-1 in Mouse and Human. Genomics. 58(3). 293–301. 23 indexed citations
19.
Nimura, Yoshinori, Motohiro Mihara, Shingo Ichimiya, et al.. (1998). p73, a geme related top53, is not mutated in esophageal carcinomas. International Journal of Cancer. 78(4). 437–440. 73 indexed citations
20.
Seki, Naohiko, Masatake Yamauchi, Toshiyuki Saito, et al.. (1993). Microdissection and Microcloning of Genomic DNA Markers from Human Chromosomal Region 11q23. Genomics. 16(1). 169–172. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026